CD8A and B-cell chronic lymphocytic leukemia: An analysis of CAR-T cells from treated CLL patients with complete disease remission showed an increase in memory CD8+ T-cell gene expression relative to non-responders to CAR T-cell therapy, and this included increased expression of TCF-1 (Fraietta et al., 2018).